Joan C. Krepinsky

2.3k total citations · 1 hit paper
68 papers, 1.9k citations indexed

About

Joan C. Krepinsky is a scholar working on Molecular Biology, Nephrology and Cell Biology. According to data from OpenAlex, Joan C. Krepinsky has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 36 papers in Nephrology and 21 papers in Cell Biology. Recurrent topics in Joan C. Krepinsky's work include Chronic Kidney Disease and Diabetes (18 papers), TGF-β signaling in diseases (13 papers) and Parathyroid Disorders and Treatments (12 papers). Joan C. Krepinsky is often cited by papers focused on Chronic Kidney Disease and Diabetes (18 papers), TGF-β signaling in diseases (13 papers) and Parathyroid Disorders and Treatments (12 papers). Joan C. Krepinsky collaborates with scholars based in Canada, United States and China. Joan C. Krepinsky's co-authors include Alistair J. Ingram, Bo Gao, Dongcheng Wu, Fang-Fang Peng, Baifang Zhang, Jeffrey G. Dickhout, Lalita Uttarwar, Renzhong Li, Bo Gao and Catherine M. Clase and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Joan C. Krepinsky

68 papers receiving 1.9k citations

Hit Papers

Endoplasmic reticulum stress as a driver and therapeutic ... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan C. Krepinsky Canada 28 894 543 464 267 205 68 1.9k
Rebecca R. Foster United Kingdom 24 911 1.0× 674 1.2× 178 0.4× 211 0.8× 96 0.5× 46 2.2k
Martine Burtin France 20 721 0.8× 616 1.1× 144 0.3× 193 0.7× 118 0.6× 47 1.7k
Xuejing Zhu China 20 701 0.8× 478 0.9× 131 0.3× 169 0.6× 144 0.7× 34 1.5k
Sumant S. Chugh United States 21 777 0.9× 1.3k 2.3× 138 0.3× 238 0.9× 211 1.0× 40 2.2k
Frank Chinga United States 5 860 1.0× 576 1.1× 131 0.3× 244 0.9× 112 0.5× 5 1.7k
Sabrina Prudente Italy 24 825 0.9× 144 0.3× 323 0.7× 393 1.5× 430 2.1× 69 1.8k
Thati Madhusudhan Germany 18 497 0.6× 372 0.7× 146 0.3× 180 0.7× 75 0.4× 33 1.4k
Miguel Arévalo Spain 24 909 1.0× 559 1.0× 84 0.2× 337 1.3× 134 0.7× 56 2.1k
Chaoyong He China 20 1.0k 1.2× 209 0.4× 207 0.4× 296 1.1× 285 1.4× 39 2.2k
Ming‐Jiang Xu China 22 626 0.7× 458 0.8× 87 0.2× 230 0.9× 128 0.6× 37 1.7k

Countries citing papers authored by Joan C. Krepinsky

Since Specialization
Citations

This map shows the geographic impact of Joan C. Krepinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan C. Krepinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan C. Krepinsky more than expected).

Fields of papers citing papers by Joan C. Krepinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan C. Krepinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan C. Krepinsky. The network helps show where Joan C. Krepinsky may publish in the future.

Co-authorship network of co-authors of Joan C. Krepinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Joan C. Krepinsky. A scholar is included among the top collaborators of Joan C. Krepinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan C. Krepinsky. Joan C. Krepinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byun, Jae Hyun, Paul Lebeau, Nikhil Uppal, et al.. (2025). Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease. Nature Reviews Nephrology. 21(5). 299–313. 16 indexed citations breakdown →
2.
Voth, Jennifer, et al.. (2024). Whole body resistance training on functional outcomes of patients with Stage 4 or 5 chronic kidney disease: A systematic review. Physiological Reports. 12(15). e16151–e16151. 1 indexed citations
3.
Li, Renzhong, et al.. (2024). Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells. Biomolecules. 14(11). 1444–1444. 2 indexed citations
4.
Platko, Khrystyna, Paul Lebeau, Melissa E. MacDonald, et al.. (2024). GDF10 is a negative regulator of vascular calcification. Journal of Biological Chemistry. 300(11). 107805–107805. 1 indexed citations
5.
Li, Renzhong, Dan Zhang, Bo Gao, et al.. (2023). A therapeutic target for CKD: activin A facilitates TGFβ1 profibrotic signaling. Cellular & Molecular Biology Letters. 28(1). 10–10. 7 indexed citations
6.
Lanktree, Matthew B., Nicolas Perrot, Andrew Smyth, et al.. (2023). A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation. Kidney International. 104(6). 1170–1184. 12 indexed citations
7.
Byun, Jae Hyun, Paul Lebeau, Khrystyna Platko, et al.. (2022). Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity. Kidney360. 3(8). 1394–1410. 23 indexed citations
8.
Li, Renzhong, et al.. (2022). Integrin β1/Cell Surface GRP78 Complex Regulates TGFβ1 and Its Profibrotic Effects in Response to High Glucose. Biomedicines. 10(9). 2247–2247. 5 indexed citations
9.
Li, Renzhong, Yaseelan Palarasah, Stéphan Troyanov, et al.. (2021). Activated Alpha 2-Macroglobulin Is a Novel Mediator of Mesangial Cell Profibrotic Signaling in Diabetic Kidney Disease. Biomedicines. 9(9). 1112–1112. 9 indexed citations
10.
Li, Renzhong, et al.. (2021). Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease. International Journal of Molecular Sciences. 22(6). 2839–2839. 7 indexed citations
11.
Krepinsky, Joan C.. (2021). Activin B , a new player in kidney fibrosis? . The Journal of Pathology. 256(4). 363–365. 5 indexed citations
12.
Mehta, Neel, Renzhong Li, Dan Zhang, et al.. (2021). miR299a-5p promotes renal fibrosis by suppressing the antifibrotic actions of follistatin. Scientific Reports. 11(1). 88–88. 6 indexed citations
13.
Mehta, Neel, Dan Zhang, Renzhong Li, et al.. (2019). Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells. Cell Communication and Signaling. 17(1). 37–37. 21 indexed citations
14.
Krieken, Richard Van, Neel Mehta, Renzhong Li, et al.. (2019). Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy. Journal of Biological Chemistry. 294(19). 7755–7768. 38 indexed citations
15.
Platko, Khrystyna, Paul Lebeau, Jae Hyun Byun, et al.. (2019). GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury. Molecular Metabolism. 27. 62–74. 21 indexed citations
16.
Al‐Hashimi, Ali, Edward G. Lynn, Šárka Lhoták, et al.. (2018). Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions. JCI Insight. 3(24). 36 indexed citations
17.
Li, Renzhong, et al.. (2018). Regulation of profibrotic responses by ADAM17 activation in high glucose requires its C-terminus and FAK. Journal of Cell Science. 131(4). 18 indexed citations
18.
Chen, Xing, Renzhong Li, Bo Gao, et al.. (2014). SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis. Journal of the American Society of Nephrology. 26(8). 1839–1854. 43 indexed citations
19.
Krepinsky, Joan C., Yanxia Li, Lieqi Liu, et al.. (2005). Akt Mediates Mechanical Strain-Induced Collagen Production by Mesangial Cells. Journal of the American Society of Nephrology. 16(6). 1661–1672. 42 indexed citations
20.
Krepinsky, Joan C., Dongcheng Wu, Alistair J. Ingram, James W. Scholey, & Damu Tang. (2002). Developments in mitogen-induced extracellular kinase 1 inhibitors and their use in the treatment of disease. Expert Opinion on Therapeutic Patents. 12(12). 1795–1811. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026